Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project (Q34252808)

31 July 2017

Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project (English)

1 reference

31 July 2017

1 reference

Rodriguez-Granger J

1

1 reference

31 July 2017

Alvargonzalez JC

2

1 reference

31 July 2017

Berardi A

3

1 reference

31 July 2017

Berner R

4

1 reference

31 July 2017

Kunze M

5

1 reference

31 July 2017

Hufnagel M

6

1 reference

31 July 2017

Melin P

7

1 reference

31 July 2017

Decheva A

8

1 reference

31 July 2017

Orefici G

9

1 reference

31 July 2017

Poyart C

10

1 reference

31 July 2017

Telford J

11

1 reference

31 July 2017

Efstratiou A

12

1 reference

31 July 2017

Killian M

13

1 reference

31 July 2017

Krizova P

14

1 reference

31 July 2017

Baldassarri L

15

1 reference

31 July 2017

Spellerberg B

16

1 reference

31 July 2017

Puertas A

17

1 reference

31 July 2017

Rosa-Fraile M

18

1 reference

31 July 2017

1 September 2012

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

31 July 2017

1 reference

31 July 2017

31

1 reference

31 July 2017

9

1 reference

31 July 2017

2097-2104

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-012-1559-0

31 July 2017

0 references

cites work

Prevalence of maternal group B streptococcal colonisation in European countries

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Group B streptococcal disease in infants: progress in prevention and continued challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Perinatal infections due to group B streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Perinatal group B streptococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Meningitis in infancy in England and Wales: follow up at age 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Maternal factors that enhance the acquisition of group-B streptococci by newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Serotype IX, a Proposed New Streptococcus agalactiae Serotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Understanding the regulation of Group B Streptococcal virulence factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Selective intrapartum anti-bioprophylaxy of group B streptococci infection of neonates: a prospective study in 2454 subsequent deliveries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Neonatal sepsis of vertical transmission: an epidemiological study from the "Grupo de Hospitales Castrillo".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Missed opportunities for preventing group B streptococcus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Prophylaxe der frühen Neugeborenensepsis durch Streptokokken der Gruppe B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Ten-year study on the effect of intrapartum antibiotic prophylaxis on early onset group B streptococcal and Escherichia coli neonatal sepsis in Australasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Invasive group B streptococcal infections in Sweden: incidence, predisposing factors and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Invasive Group B Streptococcal Infections in Finland: A Population-based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Invasive group B streptococcal infections in infants, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Invasive group B streptococcus (GBS) disease in Norway 1996-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Group B Streptococcus early-onset disease in Emilia-romagna: review after introduction of a screening-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Epidemiology of pediatric community-acquired bloodstream infections in a children hospital in Paris, France, 2001 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Group B streptococcal infections in a northern region of Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

TWO SEROLOGICAL TYPES OF GROUP B HEMOLYTIC STREPTOCOCCI WITH RELATED, BUT NOT IDENTICAL, TYPE-SPECIFIC SUBSTANCES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Immunization to prevent group B streptococcal disease: victories and vexations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

[Late onset group B Streptococcus infection: 7 year experience in a tertiary hospital (2000-2006)]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Group B streptococcal disease in nonpregnant adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

An update on vaccination against group B streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Neonatal group B streptococcal disease: from pathogenesis to preventive strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Group B Streptococcus: global incidence and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Dexamethasone treatment and cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Early-onset neonatal sepsis in the era of widespread intrapartum chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Perinatal antibiotic usage and changes in colonization and resistance rates of group B streptococcus and other pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Prevention of early onset group B streptococcal infection: screen, treat, or observe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Neonatal Sepsis and Other Infections Due to Group B Beta-Hemolytic Streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1559-0

Prevention of group B streptococcal neonatal disease. A plea for a European consensus

21 January 2018

1 reference

12 December 2020

The prevention of early-onset neonatal group B streptococcus infection: technical report from the New Zealand GBS Consensus Working Party

1 reference

12 December 2020

[Prevention of perinatal group B streptococcal disease. Spanish revised guidelines. The Spanish Society of Obstetrics and Gynecology, The Spanish Society of Neonatology, The Spanish Society of Infectious Diseases and Clinical Microbiology, The Spani

1 reference

12 December 2020

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis

1 reference

12 December 2020

Thoughts on the prevention of neonatal group B streptococcal infection.

1 reference

12 December 2020

Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention

1 reference

12 December 2020

Universal Antenatal Screening for Group B Streptococcus in Emilia-romagna

1 reference

12 December 2020

Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. II. Predictive Value of Prenatal Cultures

1 reference

12 December 2020

Intrapartum antibiotics for known maternal Group B streptococcal colonization

1 reference

12 December 2020

Clinical features and epidemiology of septicaemia and meningitis in neonates due to Streptococcus agalactiae in Copenhagen County, Denmark: a 10 year survey from 1992 to 2001.

1 reference

12 December 2020

Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.

1 reference

12 December 2020

Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system

1 reference

12 December 2020

Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection

1 reference

12 December 2020

Neonatal group B streptococcal disease in Finland: a ten-year nationwide study

1 reference

12 December 2020

Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman

1 reference

12 December 2020

Strategies for chemoprophylaxis of GBS early-onset infections

1 reference

12 December 2020

The incidence of GBS disease in neonates in different countries.

1 reference

12 December 2020

[Prevention of early-onset neonatal group B streptococcal infection: neonatal outcome after introduction of national screening guideline]

1 reference

12 December 2020

[Polish Gynecological Society's recommendations regarding diagnosis and prevention of streptococcus agalactiae infection in pregnant women and newborns]

1 reference

12 December 2020

Trends in perinatal group B streptococcal disease - United States, 2000-2006.

1 reference

12 December 2020

Decreasing incidence of perinatal Group B streptococcal disease--United States, 1993-1995.

1 reference

12 December 2020

Group B streptococcal disease in Portuguese infants younger than 90 days

1 reference

12 December 2020

Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen

1 reference

12 December 2020

Transmission of group B streptococci among parturient women and their neonates

1 reference

12 December 2020

Confirmed group B streptococcus infection: the tip of the iceberg

1 reference

12 December 2020

Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.

1 reference

12 December 2020

Consensus: perinatal prophylaxis for group B streptococcal infection

1 reference

12 December 2020

10.1007/S10096-012-1559-0

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference